Click on an icon below to learn about our current clinical research studies
If you are interested in participating in research, you can register through Permission to Contact or email us on loth.sdcrn@nhs.scot
Open to Recruitment
Probiotic: Investigating the effects of B. Subtilis Bacteria on the microbiome in Parkinson’s Disease
To determine whether B. Subtilis PXN21 has any beneficial effects on gut microbiome composition and Parkinson’s Disease symptoms
COBALT: COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial
Trialing memantine and cholinesterase inhibitors for Parkinson’s disease dementia or Dementia with Lewy Bodies.
ENROLL-HD: A Prospective Registry Study in a Global Huntington’s Disease Cohort
The largest observational study globally for Huntington’s disease.
CAN-PDP: CANnabidiol for Parkinson’s Disease Psychosis
A clinical trial investigating cannabidiol as a safe treatment for reducing hallucinations and delusions in Parkinson’s.
Other Ongoing Studies
DFP: Deep and Frequent Phenotyping; Combinatorial Biomarkers for Dementia Experimental Medicine
Tracking biological and cognitive markers of Alzheimer’s disease to detect disease change.
EVOKE/ EVOKE+: Investigating Semaglutide in People with Early Alzheimer’s Disease
A randomized, double-blind, placebo-controlled study to investigate potential benefits for reducing cognitive decline
